PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study

PHarmacist Avoidance or Reductions in Medical Costs in Patients Presenting the EMergency Department: PHARM-EM Study

Objectives:. To comprehensively classify interventions performed by emergency medicine clinical pharmacists and quantify cost avoidance generated through their accepted interventions. Design:. A multicenter, prospective, observational study was performed between August 2018 and January 2019. Setting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Megan A. Rech, PharmD, MS, FCCM, William Adams, PhD, Keaton S. Smetana, PharmD, Payal K. Gurnani, PharmD, FCCM, Megan A. Van Berkel Patel, PharmD, William J. Peppard, PharmD, FCCM, Drayton A. Hammond, PharmD, MBA, MSc, Alexander H. Flannery, PharmD, FCCM, PHARM-EM Investigators, on behalf of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section and endorsed by the Discovery Network, Giles Slocum, Josh DeMott, Michelle Malatlian, Kathryn Samai, Rachel Lazim, Kyle Allmond, Abby Bussey, Patrick Blankenship, Joanne Routsolias, Arnett Alyson Basting, Rebecca Finder, Holly Nuest, Hillcrest Elizabeth Adams, Kerri Federico, William Snow, Tina Liu, Derex Louie, Audra DeChristopher, Nadine Faulkner, Mallory Cruz, Yelena Figuerado, Adrienne Kercsak, Thomas Gregory, Lamanh Le, Tim Molinarolo, Alicia Zu Wallack, Kaitlyn Caswell, Dina Nakhleh, Cait Pfaff, Mary Hormese, Marc McDowell, Ashley Martinelli, Maggie Ma, Tara Flack, Matt McAllister, Megan Webb, Rachel Beham, Alyssa Garner, Logon Olson, Terese Poon, Ryan Balmat, Celeste Wise, Sean Hackett, Frank Rigelsky, Julia Kuroski, Matthew Nagar, Elise Metts, Dina Ali, Gavin Howington, Jason Davis, Nicole Acquisto, Kaylee Maynard, Mercy Hoang, Faisal Minhaj, Keith Kalvaitis, Michele Handzel, Kate Kokanovich, Caitlin Fronhapple, Marin Valentino, Jessica Kozakiewicz, Chara Calhoun, Kyle Weant, Lisa Hall Zimmerman, Kris Thomassian, Brett Faine, Stacey Rewitzer, Anne Zepeski, Zach Smith, Christele Francois, Brandon Huang, Cody Null, Jessica Glas, Brian Gilbert, Caitlin Brown, Francis Manuel, Toledo William Kirsch, Kristen Thomas, Curtis Geier, Jessica Rivera, Neil Umstead, John Pitts, Jerry Lepore, Bob Piavis, Giang Duong, Matthew Ford, Katrina Karpowitsch
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Acceso en línea:https://doaj.org/article/6a5492ca1195491da7f76f9c2b388509
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Objectives:. To comprehensively classify interventions performed by emergency medicine clinical pharmacists and quantify cost avoidance generated through their accepted interventions. Design:. A multicenter, prospective, observational study was performed between August 2018 and January 2019. Setting:. Community and academic hospitals in the United States. Participants:. Emergency medicine clinical pharmacists. Interventions:. Recommendations classified into one of 38 intervention categories associated with cost avoidance. Measurements and Main Results:. Eighty-eight emergency medicine pharmacists at 49 centers performed 13,984 interventions during 917 shifts that were accepted on 8,602 patients and generated $7,531,862 of cost avoidance. The quantity of accepted interventions and cost avoidance generated in six established categories were as follows: adverse drug event prevention (1,631 interventions; $2,225,049 cost avoidance), resource utilization (628; $310,582), individualization of patient care (6,122; $1,787,170), prophylaxis (24; $22,804), hands-on care (3,533; $2,836,811), and administrative/supportive tasks (2,046; $342,881). Mean cost avoidance was $538.61 per intervention, $875.60 per patient, and $8,213.59 per emergency medicine pharmacist shift. The annualized cost avoidance from an emergency medicine pharmacist was $1,971,262. The monetary cost avoidance to pharmacist salary ratio was between $1.4:1 and $10.6:1. Conclusions:. Pharmacist involvement in the care of patients presenting to the emergency department results in significant avoidance of healthcare costs, particularly in the areas of hands-on care and adverse drug event prevention. The potential monetary benefit-to-cost ratio for emergency medicine pharmacists is between $1.4:1 and $10.6:1.

Ejemplares similares